Apotea AB (publ) (STO:APOTEA)
Sweden · Delayed Price · Currency is SEK 57.89
+1.33 (2.35%)
At close: Mar 24, 2026
Apotea AB Market Cap
Apotea AB has a market cap or net worth of 6.02 billion as of March 25, 2026. Its market cap has decreased by -22.52% in one year.
Market Cap
6.02B
Enterprise Value
6.34B
Revenue
7.21B
Ranking
n/a
PE Ratio
26.34
Stock Price
57.89
Market Cap Chart
Since December 6, 2024, Apotea AB's market cap has decreased from 8.63B to 6.02B, a decrease of -30.19%. That is a compound annual growth rate of -24.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 6.02B | -37.23% |
| Dec 30, 2025 | 9.60B | 9.72% |
| Dec 30, 2024 | 8.75B | 1.35% |
| Dec 6, 2024 | 8.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 125.20B |
| Getinge AB | 50.05B |
| Sectra AB | 42.19B |
| BioArctic AB | 27.59B |
| Ambea AB | 10.49B |
| Synsam AB | 9.26B |
| Dynavox Group AB | 8.64B |
| MedCap AB | 6.94B |